You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 22, June 11, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Oncology, Other
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

MicroRNA Expression in Colon Adenocarcinoma

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Schetter and colleagues1 demonstrated that high microRNA miR-21 expression in colon adenocarcinoma tissue was associated with a low survival rate and resistance to chemotherapy. Table 2 of their article listed microRNAs with significantly higher expression in tumors, including miR-335. Recently, miR-335 was reported to be a metastasis-suppressor microRNA in breast cancer, indicating that miR-335 may prevent tumor progression.2 It is possible that miR-335 has an opposite function in breast cancer vs colon cancer.3 The expression of miR-335 might be secondary during inhibition of tumor metastasis. We would be interested in the authors' interpretation of these differing findings.

Although the authors analyzed microRNA with higher expression in tumors, it would also be valuable to know whether there is an inverse association between prognostic outcomes and the microRNA with reduced expression in tumors listed in Table 2. These microRNAs also might be useful prognostic markers.

Finally, the . . . [Full Text of this Article]

Yujiro Kida, MD, PhD; Yuan-Ping Han, PhD
Keck School of Medicine
University of Southern California
Los Angeles



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
Aaron J. Schetter, Suet Yi Leung, Jane J. Sohn, Krista A. Zanetti, Elise D. Bowman, Nozomu Yanaihara, Siu Tsan Yuen, Tsun Leung Chan, Dora L. W. Kwong, Gordon K. H. Au, Chang-Gong Liu, George A. Calin, Carlo M. Croce, and Curtis C. Harris
JAMA. 2008;299(4):425-436.
ABSTRACT | FULL TEXT  

RELATED LETTER

MicroRNA Expression in Colon Adenocarcinoma—Reply
Aaron J. Schetter and Curtis C. Harris
JAMA. 2008;299(22):2628-2629.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.